Hanne Norsgaard
Leo Pharma (Denmark)(DK)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Skin Protection and Aging, Urticaria and Related Conditions
Most-Cited Works
- → Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation(2018)129 cited
- → Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis(2015)75 cited
- → Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients(2016)73 cited
- → Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis(2016)72 cited
- → IL-23-Mediated Epidermal Hyperplasia Is Dependent on IL-6(2011)66 cited
- → Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis(2019)60 cited
- → Distinction between differentiation and senescence and the absence of increased apoptosis in human keratinocytes undergoing cellular aging in vitro(1996)60 cited
- → Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy(2014)52 cited
- → Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways(2021)50 cited
- → IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro(2022)34 cited